Indication
Chronic Myeloid Leukemia
The Chronic Myeloid Leukemia pipeline: 2 tracked drugs, 1 approved for this indication.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Chronic Myeloid Leukemia, so this list is not complete.
1 approved / phase 41 Phase 1
Compare the share prices of listed companies in Chronic Myeloid Leukemia →
Market size not yet sourced. How markets are sized ↗